Bob Löwenberg
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.02%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 452
- Acute Myeloid Leukemia Research 384
- Hematopoietic Stem Cell Transplantation 108
- Chronic Myeloid Leukemia Treatments 68
- Multiple Myeloma Research and Treatments 37
- Genetics 95
- Myeloproliferative Neoplasms: Diagnosis and Treatment 44
- Co-authors
- Peter J.M. Valk (98 shared papers)Ruud Delwel (90 shared papers)Alan K. Burnett (15 shared papers)Claudia A. J. Erpelinck-Verschueren (34 shared papers)Hartmut Doehner (15 shared papers)Gert Jan Ossenkoppele (49 shared papers)Elihu H. Estey (10 shared papers)Jan J. Cornelissen (56 shared papers)
- Journals
- Blood (222 papers)British Journal of Haematology (39 papers)Leukemia (32 papers)Journal of Clinical Oncology (27 papers)Haematologica (18 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Bob Löwenberg
643 papers receiving 58.2k citations
Bob Löwenberg's Hit Papers
Peers
Comparison fields: 5 of 176
- Hematology 38.7k
- Genetics 9.5k
- Cancer Research 5.5k
- Oncology 9.9k
- Immunology 7.2k
Countries citing papers authored by Bob Löwenberg
This map shows the geographic impact of Bob Löwenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bob Löwenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bob Löwenberg more than expected).
Fields of papers citing papers by Bob Löwenberg
This network shows the impact of papers produced by Bob Löwenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bob Löwenberg. The network helps show where Bob Löwenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Bob Löwenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 656 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel Hit paper breakdown → | 2016 | 4589 |
| 2 | Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet Hit paper breakdown → | 2009 | 2839 |
| 3 | Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia Hit paper breakdown → | 2003 | 2381 |
| 4 | Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation Hit paper breakdown → | 2010 | 2292 |
| 5 | Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN Hit paper breakdown → | 2022 | 2084 |
| 6 | International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data Hit paper breakdown → | 2022 | 1856 |
| 7 | Prognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia Hit paper breakdown → | 2004 | 1132 |
| 8 | Acute Myeloid Leukemia Hit paper breakdown → | 1999 | 1100 |
| 9 | Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse Hit paper breakdown → | 2001 | 750 |
| 10 | Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet Hit paper breakdown → | 2008 | 744 |
| 11 | High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia Hit paper breakdown → | 2009 | 698 |
| 12 | DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia Hit paper breakdown → | 2010 | 690 |
| 13 | A 17-gene stemness score for rapid determination of risk in acute leukaemia Hit paper breakdown → | 2016 | 682 |
| 14 | Therapeutic Advances in Acute Myeloid Leukemia Hit paper breakdown → | 2011 | 665 |
| 15 | Molecular Minimal Residual Disease in Acute Myeloid Leukemia Hit paper breakdown → | 2018 | 646 |
| 16 | A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia Hit paper breakdown → | 2014 | 524 |
| 17 | 2005 | 508 | |
| 18 | Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype Hit paper breakdown → | 2008 | 494 |
| 19 | 2009 | 484 | |
| 20 | Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet Hit paper breakdown → | 2019 | 470 |
About Bob Löwenberg
Bob Löwenberg is a scholar working on Hematology, Genetics, Immunology, Oncology and Molecular Biology, having authored 656 papers that have together received 60.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (384 papers), Hematopoietic Stem Cell Transplantation (108 papers), Acute Lymphoblastic Leukemia research (86 papers), Retinoids in leukemia and cellular processes (69 papers), Chronic Myeloid Leukemia Treatments (68 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (44 papers), Immune Cell Function and Interaction (42 papers) and Multiple Myeloma Research and Treatments (37 papers). The work is most often cited by research in Hematology (38.7k citations), Genetics (9.5k citations), Cancer Research (5.5k citations), Oncology (9.9k citations) and Immunology (7.2k citations). Bob Löwenberg has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Peter J.M. Valk, Ruud Delwel, Alan K. Burnett, Claudia A. J. Erpelinck-Verschueren, Hartmut Doehner, Gert Jan Ossenkoppele, Elihu H. Estey, Jan J. Cornelissen, Pieter Sonneveld and Miguel Ángel Sanz. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Journal of Clinical Oncology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.